T. Rowe Price
Companies on this map3
Rounds named in5
Led0
Most often enters atSeries B
Counted from this site's funding record only (the AI for Science companies it tracks), not the firm's whole portfolio. Every round links the page it was read from; this page compiles those sources, and where one is wrong, the source governs. Tell us and we fix it.
Rounds that name it
| Announced | Company | Round | Role | Round size | Source |
|---|---|---|---|---|---|
| 2026-09-23 |  Enveda | Series E | Participant | $311M | Announced · biospace.com ↗ |
| 2023-09-14 |  Generate:Biomedicines | Series C | Participant | $273M | Announced · generatebiomedicines.com ↗ |
| 2023-08-21 |  Genesis Molecular AI (formerly Genesis Therapeutics) | Series B | Participant | $200M | Announced · biopharmadive.com ↗ |
| 2021-11-18 | Generate:Biomedicines | Series B | Participant | $370M | Announced · generatebiomedicines.com ↗ |
| 2020-12-02 | Genesis Molecular AI (formerly Genesis Therapeutics) | Series A | Participant | $52M | Announced · biospace.com ↗ |